 | • レポートコード：MR2211MG11480 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療機器 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、関節内補充療法用注射のグローバル市場規模と予測を記載しています。・関節内補充療法用注射のグローバル市場：売上、2017年-2022年、2023年-2028年 ・関節内補充療法用注射のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 関節内補充療法用注射のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「１回注射」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 関節内補充療法用注射のグローバル主要企業は、Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfengなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、関節内補充療法用注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の関節内補充療法用注射市場：タイプ別、2017年-2022年、2023年-2028年 世界の関節内補充療法用注射市場：タイプ別市場シェア、2021年 ・１回注射、３回注射、５回注射 世界の関節内補充療法用注射市場：用途別、2017年-2022年、2023年-2028年 世界の関節内補充療法用注射市場：用途別市場シェア、2021年 ・病院、診療所、その他 世界の関節内補充療法用注射市場：地域・国別、2017年-2022年、2023年-2028年 世界の関節内補充療法用注射市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における関節内補充療法用注射のグローバル売上、2017年-2022年 ・主要企業における関節内補充療法用注射のグローバル売上シェア、2021年 ・主要企業における関節内補充療法用注射のグローバル販売量、2017年-2022年 ・主要企業における関節内補充療法用注射のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng ************************************************************* ・調査・分析レポートの概要 関節内補充療法用注射市場の定義 市場セグメント 世界の関節内補充療法用注射市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の関節内補充療法用注射市場規模 世界の関節内補充療法用注射市場規模：2021年 VS 2028年 世界の関節内補充療法用注射市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの関節内補充療法用注射の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の関節内補充療法用注射製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：１回注射、３回注射、５回注射 関節内補充療法用注射のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 関節内補充療法用注射の用途別グローバル売上・予測 ・地域別市場分析 地域別関節内補充療法用注射市場規模 2021年と2028年 地域別関節内補充療法用注射売上・予測 北米市場 - アメリカの関節内補充療法用注射市場規模2017年-2028年 - カナダの関節内補充療法用注射市場規模2017年-2028年 - メキシコの関節内補充療法用注射市場規模2017年-2028年 ヨーロッパ市場 - ドイツの関節内補充療法用注射市場規模2017年-2028年 - フランスの関節内補充療法用注射市場規模2017年-2028年 - イギリスの関節内補充療法用注射市場規模2017年-2028年 - イタリアの関節内補充療法用注射市場規模2017年-2028年 - ロシアの関節内補充療法用注射市場規模2017年-2028年 アジア市場 - 中国の関節内補充療法用注射市場規模2017年-2028年 - 日本の関節内補充療法用注射市場規模2017年-2028年 - 韓国の関節内補充療法用注射市場規模2017年-2028年 - 東南アジアの関節内補充療法用注射市場規模2017年-2028年 - インドの関節内補充療法用注射市場規模2017年-2028年 南米市場 - ブラジルの関節内補充療法用注射市場規模2017年-2028年 - アルゼンチンの関節内補充療法用注射市場規模2017年-2028年 中東・アフリカ市場 - トルコの関節内補充療法用注射市場規模2017年-2028年 - イスラエルの関節内補充療法用注射市場規模2017年-2028年 - サウジアラビアの関節内補充療法用注射市場規模2017年-2028年 - UAEの関節内補充療法用注射市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sanofi、 Anika Therapeutics、 Seikagaku、 Zimmer Biomet、 Bioventus、 Ferring、 LG Chem、 Freda、 Haohai Biological、 Shanghai Jingfeng ... |
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report contains market size and forecasts of Injectable Viscosupplementation for Joint in global, including the following market information:
Global Injectable Viscosupplementation for Joint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Viscosupplementation for Joint Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Injectable Viscosupplementation for Joint companies in 2021 (%)
The global Injectable Viscosupplementation for Joint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Viscosupplementation for Joint include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Viscosupplementation for Joint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Viscosupplementation for Joint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Type, 2021 (%)
Single Injection
Three Injection
Five Injection
Global Injectable Viscosupplementation for Joint Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Injectable Viscosupplementation for Joint Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Injectable Viscosupplementation for Joint Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Viscosupplementation for Joint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Viscosupplementation for Joint revenues share in global market, 2021 (%)
Key companies Injectable Viscosupplementation for Joint sales in global market, 2017-2022 (Estimated), (Units)
Key companies Injectable Viscosupplementation for Joint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
1 Introduction to Research & Analysis Reports
1.1 Injectable Viscosupplementation for Joint Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Injectable Viscosupplementation for Joint Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Injectable Viscosupplementation for Joint Overall Market Size
2.1 Global Injectable Viscosupplementation for Joint Market Size: 2021 VS 2028
2.2 Global Injectable Viscosupplementation for Joint Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Injectable Viscosupplementation for Joint Sales: 2017-2028
3 Company Landscape
3.1 Top Injectable Viscosupplementation for Joint Players in Global Market
3.2 Top Global Injectable Viscosupplementation for Joint Companies Ranked by Revenue
3.3 Global Injectable Viscosupplementation for Joint Revenue by Companies
3.4 Global Injectable Viscosupplementation for Joint Sales by Companies
3.5 Global Injectable Viscosupplementation for Joint Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Injectable Viscosupplementation for Joint Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Injectable Viscosupplementation for Joint Product Type
3.8 Tier 1, Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Players in Global Market
3.8.1 List of Global Tier 1 Injectable Viscosupplementation for Joint Companies
3.8.2 List of Global Tier 2 and Tier 3 Injectable Viscosupplementation for Joint Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Injectable Viscosupplementation for Joint Market Size Markets, 2021 & 2028
4.1.2 Single Injection
4.1.3 Three Injection
4.1.4 Five Injection
4.2 By Type – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
4.2.1 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
4.2.2 By Type – Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
4.2.3 By Type – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
4.3 By Type – Global Injectable Viscosupplementation for Joint Sales & Forecasts
4.3.1 By Type – Global Injectable Viscosupplementation for Joint Sales, 2017-2022
4.3.2 By Type – Global Injectable Viscosupplementation for Joint Sales, 2023-2028
4.3.3 By Type – Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
4.4 By Type – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
5.2.1 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
5.2.2 By Application – Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
5.2.3 By Application – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
5.3 By Application – Global Injectable Viscosupplementation for Joint Sales & Forecasts
5.3.1 By Application – Global Injectable Viscosupplementation for Joint Sales, 2017-2022
5.3.2 By Application – Global Injectable Viscosupplementation for Joint Sales, 2023-2028
5.3.3 By Application – Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
5.4 By Application – Global Injectable Viscosupplementation for Joint Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Injectable Viscosupplementation for Joint Market Size, 2021 & 2028
6.2 By Region – Global Injectable Viscosupplementation for Joint Revenue & Forecasts
6.2.1 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2017-2022
6.2.2 By Region – Global Injectable Viscosupplementation for Joint Revenue, 2023-2028
6.2.3 By Region – Global Injectable Viscosupplementation for Joint Revenue Market Share, 2017-2028
6.3 By Region – Global Injectable Viscosupplementation for Joint Sales & Forecasts
6.3.1 By Region – Global Injectable Viscosupplementation for Joint Sales, 2017-2022
6.3.2 By Region – Global Injectable Viscosupplementation for Joint Sales, 2023-2028
6.3.3 By Region – Global Injectable Viscosupplementation for Joint Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.4.2 By Country – North America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.4.3 US Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.4 Canada Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.4.5 Mexico Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.5.2 By Country – Europe Injectable Viscosupplementation for Joint Sales, 2017-2028
6.5.3 Germany Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.4 France Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.5 U.K. Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.6 Italy Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.7 Russia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.8 Nordic Countries Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.5.9 Benelux Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.6.2 By Region – Asia Injectable Viscosupplementation for Joint Sales, 2017-2028
6.6.3 China Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.4 Japan Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.5 South Korea Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.6 Southeast Asia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.6.7 India Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.7.2 By Country – South America Injectable Viscosupplementation for Joint Sales, 2017-2028
6.7.3 Brazil Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.7.4 Argentina Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Injectable Viscosupplementation for Joint Sales, 2017-2028
6.8.3 Turkey Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.4 Israel Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.5 Saudi Arabia Injectable Viscosupplementation for Joint Market Size, 2017-2028
6.8.6 UAE Injectable Viscosupplementation for Joint Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Injectable Viscosupplementation for Joint Major Product Offerings
7.1.4 Sanofi Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi Key News
7.2 Anika Therapeutics
7.2.1 Anika Therapeutics Corporate Summary
7.2.2 Anika Therapeutics Business Overview
7.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Major Product Offerings
7.2.4 Anika Therapeutics Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.2.5 Anika Therapeutics Key News
7.3 Seikagaku
7.3.1 Seikagaku Corporate Summary
7.3.2 Seikagaku Business Overview
7.3.3 Seikagaku Injectable Viscosupplementation for Joint Major Product Offerings
7.3.4 Seikagaku Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.3.5 Seikagaku Key News
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Corporate Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Major Product Offerings
7.4.4 Zimmer Biomet Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.4.5 Zimmer Biomet Key News
7.5 Bioventus
7.5.1 Bioventus Corporate Summary
7.5.2 Bioventus Business Overview
7.5.3 Bioventus Injectable Viscosupplementation for Joint Major Product Offerings
7.5.4 Bioventus Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.5.5 Bioventus Key News
7.6 Ferring
7.6.1 Ferring Corporate Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Injectable Viscosupplementation for Joint Major Product Offerings
7.6.4 Ferring Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.6.5 Ferring Key News
7.7 LG Chem
7.7.1 LG Chem Corporate Summary
7.7.2 LG Chem Business Overview
7.7.3 LG Chem Injectable Viscosupplementation for Joint Major Product Offerings
7.7.4 LG Chem Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.7.5 LG Chem Key News
7.8 Freda
7.8.1 Freda Corporate Summary
7.8.2 Freda Business Overview
7.8.3 Freda Injectable Viscosupplementation for Joint Major Product Offerings
7.8.4 Freda Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.8.5 Freda Key News
7.9 Haohai Biological
7.9.1 Haohai Biological Corporate Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Injectable Viscosupplementation for Joint Major Product Offerings
7.9.4 Haohai Biological Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.9.5 Haohai Biological Key News
7.10 Shanghai Jingfeng
7.10.1 Shanghai Jingfeng Corporate Summary
7.10.2 Shanghai Jingfeng Business Overview
7.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Major Product Offerings
7.10.4 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales and Revenue in Global (2017-2022)
7.10.5 Shanghai Jingfeng Key News
8 Global Injectable Viscosupplementation for Joint Production Capacity, Analysis
8.1 Global Injectable Viscosupplementation for Joint Production Capacity, 2017-2028
8.2 Injectable Viscosupplementation for Joint Production Capacity of Key Manufacturers in Global Market
8.3 Global Injectable Viscosupplementation for Joint Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Injectable Viscosupplementation for Joint Supply Chain Analysis
10.1 Injectable Viscosupplementation for Joint Industry Value Chain
10.2 Injectable Viscosupplementation for Joint Upstream Market
10.3 Injectable Viscosupplementation for Joint Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Injectable Viscosupplementation for Joint Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer